Does PEMBROLIZUMAB Cause Extravasation? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Extravasation have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
8
Reports of Extravasation with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Extravasation From PEMBROLIZUMAB?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Extravasation Listed in the Official Label?
Yes, Extravasation is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Extravasation?
IRON SUCROSE (122)
FERRIC CARBOXYMALTOSE (103)
DOXORUBICIN (92)
FLUOROURACIL (90)
OXALIPLATIN (90)
IOHEXOL (89)
RITUXIMAB (77)
CYCLOPHOSPHAMIDE (65)
NIVOLUMAB (55)
INFLIXIMAB (53)
Which PEMBROLIZUMAB Alternatives Have Lower Extravasation Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G